慢乙肝的终生治疗 – 适应症和可接受性
——  作者:    时间:2008-08-06     阅读数: 487

简介:What treatment should be offered to patients? Cumulative evidence to date suggests that the judicious use of nucleos(t)ide in CHB patients is the most preventive strategy against the development of antiviral-resistant HBV.

请登录后查看详细内容

发表评论

全部评论